220 related articles for article (PubMed ID: 25506899)
1. Pancreatic cancer metastasis: are we being pre-EMTed?
Das S; Batra SK
Curr Pharm Des; 2015; 21(10):1249-55. PubMed ID: 25506899
[TBL] [Abstract][Full Text] [Related]
2. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
Jiang JH; Liu C; Cheng H; Lu Y; Qin Y; Xu YF; Xu J; Long J; Liu L; Ni QX; Yu XJ
Biochim Biophys Acta; 2015 Jan; 1855(1):43-9. PubMed ID: 25432020
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
5. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition and the generation of stem-like cells in pancreatic cancer.
Rhim AD
Pancreatology; 2013; 13(2):114-7. PubMed ID: 23561968
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer.
Yamada S; Fuchs BC; Fujii T; Shimoyama Y; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y; Nakao A
Surgery; 2013 Nov; 154(5):946-54. PubMed ID: 24075276
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment participates in metastasis of pancreatic cancer.
Ren B; Cui M; Yang G; Wang H; Feng M; You L; Zhao Y
Mol Cancer; 2018 Jul; 17(1):108. PubMed ID: 30060755
[TBL] [Abstract][Full Text] [Related]
9. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
10. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.
Nomura A; Banerjee S; Chugh R; Dudeja V; Yamamoto M; Vickers SM; Saluja AK
Oncotarget; 2015 Apr; 6(10):8313-22. PubMed ID: 25829252
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis.
Park JS; Lee JH; Lee YS; Kim JK; Dong SM; Yoon DS
Oncotarget; 2016 Jul; 7(27):42539-42552. PubMed ID: 27285767
[TBL] [Abstract][Full Text] [Related]
13. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor signaling and pancreatic cancer cell EMT.
Li Z; Guo J; Xie K; Zheng S
Curr Pharm Des; 2015; 21(10):1262-7. PubMed ID: 25506892
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
Waghray M; Yalamanchili M; Dziubinski M; Zeinali M; Erkkinen M; Yang H; Schradle KA; Urs S; Pasca Di Magliano M; Welling TH; Palmbos PL; Abel EV; Sahai V; Nagrath S; Wang L; Simeone DM
Cancer Discov; 2016 Aug; 6(8):886-99. PubMed ID: 27184426
[TBL] [Abstract][Full Text] [Related]
16. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
17. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer.
Kuwada K; Kagawa S; Yoshida R; Sakamoto S; Ito A; Watanabe M; Ieda T; Kuroda S; Kikuchi S; Tazawa H; Fujiwara T
J Exp Clin Cancer Res; 2018 Dec; 37(1):307. PubMed ID: 30537992
[TBL] [Abstract][Full Text] [Related]
18. SNX6 predicts poor prognosis and contributes to the metastasis of pancreatic cancer cells via activating epithelial-mesenchymal transition.
Hu P; Liang Y; Hu Q; Wang H; Cai Z; He J; Cai J; Liu M; Qin Y; Yu X; Jiang C; Zhang B; Wang W
Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1075-1084. PubMed ID: 30307473
[TBL] [Abstract][Full Text] [Related]
19. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
20. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
